Edition:
United Kingdom

Poxel SA (POXEL.PA)

POXEL.PA on Paris Stock Exchange

6.44EUR
19 Jul 2019
Change (% chg)

€-0.02 (-0.31%)
Prev Close
€6.46
Open
€6.45
Day's High
€6.57
Day's Low
€6.39
Volume
35,403
Avg. Vol
122,090
52-wk High
€9.18
52-wk Low
€4.92

About

Poxel SAS is a France-based company principally engaged in the biopharmaceutical sector. The Company develops drugs with a focus on Type 2 diabetes. The Company aims at developing drugs from preclinical to phase 2 clinical proof of concept. Its lead product, Imeglimin, is in clinical phase 2 study for Type 2 diabetes indication.... (more)

Overall

Beta: 0.84
Market Cap(Mil.): €167.19
Shares Outstanding(Mil.): 25.88
Dividend: --
Yield (%): --

Financials

  POXEL.PA Industry Sector
P/E (TTM): 12.10 95.83 34.03
EPS (TTM): 0.53 -- --
ROI: 35.34 7.72 12.70
ROE: 36.01 8.23 17.29

Earnings vs. Estimates